AIM ImmunoTech
AIM • AMEX • Stock Fundamentals
AIM ImmunoTech is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Thomas K. Equels, with a market cap of $3.4M.
Market Cap$3.4M
Employees28.0
CEOThomas K. Equels
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 3 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
AIM ImmunoTech FAQ
Common questions about AIM ImmunoTech
AIM ImmunoTech (AIM) has a market capitalization of $3.4M and trades on AMEX.
AIM ImmunoTech has approximately 28 employees.